The Open Database Of The Corporate World

Prothya Biosolutions Belgium

Company Number
0462229645
Status
Situation Normale
Incorporation Date
Please log in to see this data
Company Type
Société à responsabilité limitée
Jurisdiction
Belgium
Registered Address
  • Avenue de Tyras 109
  • Bruxelles
  • 1120
  • Belgium
Industry Codes
  • 85145: Bloedbanken, organenbanken en dergelijke (NACE-BEL 2003)
  • 86902: Activiteiten van bloedtransfusiecentra en bloed- en organenbanken (NACE-BEL 2008)
  • 21201: Vervaardiging van geneesmiddelen (NACE-BEL 2008)
  • 21100: Vervaardiging van farmaceutische grondstoffen (NACE-BEL 2008)
  • 21.100: Vervaardiging van farmaceutische grondstoffen (NACE-BEL 2025)
  • 86.992: Activiteiten van bloedtransfusiecentra, bloedbanken, spermabanken, organenbanken en dergelijke (NACE-BEL 2025)
  • 85.14: Other human health activities (European Community NACE Rev 1.1)
  • 86.90: Other human health activities (European Community NACE Rev 2)
  • 8690: Other human health activities (UN ISIC Rev 4)
  • 21.20: Manufacture of pharmaceutical preparations (European Community NACE Rev 2)
  • 2100: Manufacture of pharmaceuticals, medicinal chemical and botanical products (UN ISIC Rev 4)
  • 21.10: Manufacture of basic pharmaceutical products (European Community NACE Rev 2)
  • 86.9: Other human health activities (European Community NACE Rev 2)
  • 869: Other human health activities (UN ISIC Rev 4)
Alternative Names
  • “Prothya” of “Prothya Biosolutions” (abbreviated name in NL)

Branches


Identifiers

Identifier System Identifier Categories
LEI Please log in to view this data details

Industry codes

Code Description Code scheme
86.992 Activiteiten van bloedtransfusiecentra, bloedbanken, spermabanken, organenbanken en dergelijke NACE-BEL 2025 details
85145 Bloedbanken, organenbanken en dergelijke NACE-BEL 2003 details
21100 Vervaardiging van farmaceutische grondstoffen NACE-BEL 2008 details
86902 Activiteiten van bloedtransfusiecentra en bloed- en organenbanken NACE-BEL 2008 details
21.100 Vervaardiging van farmaceutische grondstoffen NACE-BEL 2025 details

* While we strive to keep this information correct and up-to-date, it is not the primary source, and the company registry should always be referred to for definitive information